Papular xanthoma

Rare Dermatologic Disorder MONDO:0015536 Pathograph 5 Show in embeddings browser Non-Langerhans cell histiocytosis Cutaneous histiocytosis

Papular xanthoma is a rare cutaneous non-Langerhans cell histiocytosis in which papules are composed predominantly of xanthomatized macrophages. The classic clinicopathologic series frames it as a normolipemic skin-limited disorder, although pediatric exceptions with abnormal lipid profiles have been reported.

Ask OpenScientist

Ask a research question about Papular xanthoma. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

🏷

Classifications

Harrison's Part
DERMATOLOGY
⚙

Pathophysiology

1
Xanthomatized Dermal Macrophage Infiltration
Papular xanthoma lesions represent a monomorphous non-Langerhans cell histiocytosis reaction pattern dominated by xanthomatized macrophages in skin. Foamy macrophage accumulation and Touton giant cells produce the yellow papular clinical morphology and anchor the diagnosis histologically.
xanthomatized macrophage CL:0000235 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves xanthomatized macrophage, annotated with macrophage (CL:0000235). CL:0000235 is a cell type from the Cell Ontology.
macrophage derived foam cell differentiation GO:0010742 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves macrophage derived foam cell differentiation (GO:0010742). GO:0010742 is a biological process from the Gene Ontology. lipid metabolic process GO:0006629 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves lipid metabolic process (GO:0006629). GO:0006629 is a biological process from the Gene Ontology.
Downstream
Solitary or multiple papules Dermal xanthomatized macrophage accumulation produces the papular lesion morphology described clinically.
Yellow xanthomatous eyelid or periocular lesions Xanthomatized macrophage infiltration in papular xanthoma is associated with xanthomatous lesions on the eyelids or periocular region.
Foamy Xanthomatized Macrophage Infiltrate The pathophysiologic macrophage accumulation is directly observed as the foamy or xanthomatized dermal infiltrate on biopsy.
Touton Giant Cells Xanthomatous macrophage-rich lesions are histologically accompanied by Touton-type giant cells in the clinicopathologic series.
Show evidence (2 references)
PMID:12028152 SUPPORT Human clinical
"PX represents a monomorphous reaction pattern of n-LCH characterized by the presence of predominantly xanthomatized macrophages."
The 10-case clinicopathologic series defines papular xanthoma as a non-Langerhans cell histiocytosis pattern dominated by xanthomatized macrophages.
PMID:12028152 SUPPORT Human clinical
"Histology showed moderately well circumscribed exoendophytic papules with a regular epidermis and a dense infiltration of xanthomatized macrophages interspersed by numerous Touton type giant cells."
This directly links the clinical papule to dense xanthomatized macrophage infiltration and Touton giant cells.
✶

Histopathology

2
Foamy Xanthomatized Macrophage Infiltrate
Biopsy shows a circumscribed dermal papule with dense foamy or xanthomatized macrophages.
Show evidence (1 reference)
PMID:12028152 SUPPORT Human clinical
"Histology showed moderately well circumscribed exoendophytic papules with a regular epidermis and a dense infiltration of xanthomatized macrophages interspersed by numerous Touton type giant cells."
This exact histologic description supports foamy/xanthomatized macrophage infiltrates as a diagnostic microscopic feature.
Touton Giant Cells
Touton-type giant cells are commonly described in classic papular xanthoma histology and help place the lesion among xanthomatous histiocytoses. A precise HPO term for Touton giant cells was not found locally with OAK, and no finding_term is assigned; an HPO new term request may be needed.
Show evidence (1 reference)
PMID:12028152 SUPPORT Human clinical
"Histology showed moderately well circumscribed exoendophytic papules with a regular epidermis and a dense infiltration of xanthomatized macrophages interspersed by numerous Touton type giant cells."
The series explicitly identifies numerous Touton-type giant cells in papular xanthoma histology.
⬡

Pathograph

Use Group by to collapse related nodes into one box. Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Referential integrity issues (2):
  • Target 'Foamy Xanthomatized Macrophage Infiltrate' (from 'Xanthomatized Dermal Macrophage Infiltration') not found in named elements
  • Target 'Touton Giant Cells' (from 'Xanthomatized Dermal Macrophage Infiltration') not found in named elements
Pathograph: causal mechanism network for Papular xanthoma Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

2
Solitary or multiple papules Dermatologic HP:0200034 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Papule (HP:0200034). HP:0200034 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:12028152 SUPPORT Human clinical
"In this clinicopathologic study, papular xanthoma presented clinically mainly as solitary papule, with a male to female ratio of4 : 1, in an age range from 13 to 57 years and a biphasic occurrence: in the young adolescence and middle ages."
The series supports papules as the core clinical morphology and documents adolescent-to-adult presentations without using this as a frequency field.
PMID:20199419 SUPPORT Human clinical
"We report a 10-year-old girl with multiple papule xanthomas on her face that had an abnormal lipid profile."
This pediatric case supports that papular xanthoma can present with multiple facial papules and that normolipemia is not absolute.
Yellow xanthomatous eyelid or periocular lesions Dermatologic HP:0025507 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Yellow papule (HP:0025507). HP:0025507 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:28500693 SUPPORT Human clinical
"On the other hand, different types of normolipemic disorders may also cause xanthomatous eyelid lesions. Among these, Langerhans cell histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma disseminatum,..."
Explicitly lists papular xanthoma among normolipemic non-Langerhans cell histiocytoses that cause xanthomatous eyelid lesions.
PMID:21396554 SUPPORT Human clinical
"Histiocytosis is rare but does occur in prevalent locations."
This periorbital-lesion review supports that histiocytoses can occur around the eyes, but the abstract is not specific to papular xanthoma.
PMID:12028152 SUPPORT Human clinical
"It was predominantly located on the trunk, the extremities, and rarely on the head."
This supports head involvement as a rare site in the clinicopathologic series, but only partially supports a periocular/head-involvement claim because the series emphasized trunk and extremity involvement.
💊

Medical Actions

1
Observation and supportive follow-up
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
No disease-specific standard pharmacotherapy is established in the fetched abstracts. Management is therefore represented conservatively as supportive follow-up after diagnosis, lipid evaluation, and assessment for systemic or associated disorders when clinically indicated.
Show evidence (1 reference)
PMID:28500693 SUPPORT Human clinical
"It is necessary to obtain a thorough history and exclude XP and then perform detailed dermatological and systemic examination, biopsy for histopathologic confirmation, and appropriate specific imaging screens."
This supports careful diagnostic evaluation and follow-up for xanthomatous eyelid lesions, but it is not a papular-xanthoma-specific treatment trial.
🔬

Biochemical Markers

1
Normal Serum Lipid Profile (Normolipemia) (Normal)
Context: Papular xanthoma is classically a normolipemic cutaneous non-Langerhans cell histiocytosis with normal serum cholesterol and triglyceride concentrations, distinguishing it from dyslipidemic cutaneous xanthomas.
Show evidence (3 references)
PMID:12028152 SUPPORT Human clinical
"Papular xanthoma (PX) is one of several clinicopathologic variants of normolipemic cutaneous non-Langerhans cell histiocytoses (n-LCH)."
Defines papular xanthoma as a normolipemic cutaneous non-Langerhans cell histiocytosis.
PMID:20199419 SUPPORT Human clinical
"While this rare disorder has been documented in children, all but one reported in the literature had a normal lipid profile. We report a 10-year-old girl with multiple papule xanthomas on her face that had an abnormal lipid profile. To our knowledge this is only the second reported case of..."
Confirms that normal serum lipid profiles are the rule in pediatric as well as adult papular xanthoma, while documenting the second reported pediatric case with an abnormal lipid profile.
PMID:28500693 SUPPORT Human clinical
"On the other hand, different types of normolipemic disorders may also cause xanthomatous eyelid lesions. Among these, Langerhans cell histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma disseminatum,..."
Places papular xanthoma among normolipemic disorders that cause xanthomatous lesions, contrasting it with hyperlipidemia-associated xanthelasma palpebrarum.
🔬

Diagnosis

3
Skin biopsy with histology and immunohistochemistry
Diagnosis is established by biopsy demonstrating xanthomatized macrophages and Touton giant cells, with immunohistochemistry supporting a non-Langerhans macrophage lineage.
biopsy of skin NCIT:C51692 NCI Thesaurus (NCIT)
Show evidence (2 references)
PMID:12028152 SUPPORT Human clinical
"OBJECTIVE: The purpose of this study was to identify the clinical, histological and immunohistochemical characteristics of PX."
The foundational series used clinicopathologic, histologic, and immunohistochemical characterization to define papular xanthoma.
PMID:12028152 SUPPORT Human clinical
"Immunohistochemically mono- and multinucleated macrophages were consistently positive with KiM1p; while only giant cells were labeled with KP1 (CD68), the reactivity with HAM 56 was much more variable."
This supports immunohistochemistry as part of diagnostic confirmation and documents macrophage marker reactivity.
Immunohistochemical macrophage marker profile
Papular xanthoma immunohistochemistry supports non-Langerhans macrophage lineage: mono- and multinucleated macrophages are KiM1p-positive, Touton giant cells are KP1/CD68-positive, and factor XIIIa and CD1a are negative.
immunohistochemistry NCIT:C23020 NCI Thesaurus (NCIT)
Markers: KiM1p positive; KP1/CD68 positive in giant cells; factor XIIIa negative; CD1a negative
Show evidence (2 references)
PMID:12028152 SUPPORT Human clinical
"Immunohistochemically mono- and multinucleated macrophages were consistently positive with KiM1p; while only giant cells were labeled with KP1 (CD68), the reactivity with HAM 56 was much more variable."
This documents KiM1p positivity in mono- and multinucleated macrophages and KP1/CD68 labeling in Touton-type giant cells.
PMID:12028152 SUPPORT Human clinical
"Staining for factor XIIIa and CD1a were negative."
This documents the negative factor XIIIa and CD1a components of the diagnostic immunohistochemical profile.
Lipid and systemic evaluation
Papular xanthoma is classically normolipemic, but lipid testing is still clinically relevant because abnormal pediatric lipid profiles have been reported and eyelid xanthomatous lesions may overlap with systemic disorders.
Show evidence (2 references)
PMID:20199419 SUPPORT Human clinical
"Papular xanthoma is a rare normolipemic xanthomatous skin disease which primarily occurs in adults."
This supports normolipemia as the classic framing of papular xanthoma.
PMID:20199419 SUPPORT Human clinical
"While this rare disorder has been documented in children, all but one reported in the literature had a normal lipid profile."
This supports lipid-profile evaluation and shows that normal lipids are usual but not universal in reported pediatric disease.
📈

Progression

2
Biphasic adolescent and adult onset
Age: 13 to 57 years (young adolescence and middle age)
Papular xanthoma primarily occurs in adults, with the 10-case clinicopathologic series documenting an age range of 13 to 57 years and a biphasic distribution peaking in young adolescence and middle age.
Show evidence (2 references)
PMID:12028152 SUPPORT Human clinical
"In this clinicopathologic study, papular xanthoma presented clinically mainly as solitary papule, with a male to female ratio of4 : 1, in an age range from 13 to 57 years and a biphasic occurrence: in the young adolescence and middle ages."
Establishes the 13 to 57 year age range and biphasic adolescent and middle-age distribution in the clinicopathologic series.
PMID:20199419 SUPPORT Human clinical
"Papular xanthoma is a rare normolipemic xanthomatous skin disease which primarily occurs in adults."
Confirms that papular xanthoma primarily presents in adulthood.
Childhood
Age: Childhood
Less commonly, papular xanthoma presents in children, including with multiple facial papules.
Show evidence (1 reference)
PMID:20199419 SUPPORT Human clinical
"While this rare disorder has been documented in children, all but one reported in the literature had a normal lipid profile. We report a 10-year-old girl with multiple papule xanthomas on her face that had an abnormal lipid profile."
Documents childhood presentation with multiple facial papular xanthomas.
📊

Prevalence

1
Worldwide
Cases/families reported in the literature Rare
Population-level point prevalence is not established; papular xanthoma is a rare cutaneous non-Langerhans cell histiocytosis documented through small clinicopathologic series and isolated case reports, with a 4:1 male-to-female ratio reported in the 10-case clinicopathologic study.
Show evidence (2 references)
PMID:12028152 SUPPORT Human clinical
"In this clinicopathologic study, papular xanthoma presented clinically mainly as solitary papule, with a male to female ratio of4 : 1, in an age range from 13 to 57 years and a biphasic occurrence: in the young adolescence and middle ages."
Documents the 10-case clinicopathologic series and its 4:1 male-to-female distribution.
PMID:12028152 SUPPORT Human clinical
"This series confirms PX as a rare, but distinguished clinicopathologic entity in the spectrum of n-LCH of the skin."
Confirms papular xanthoma as a rare entity within cutaneous non-Langerhans cell histiocytoses.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Papular xanthoma:

Juvenile xanthogranuloma
Overlapping Features Juvenile xanthogranuloma is the key clinical and histopathologic mimic, especially in infants and children with multiple yellow papules.
Distinguishing Features
  • Papular xanthoma is modeled as a more monomorphous xanthomatized macrophage pattern.
  • Factor XIIIa staining is negative in papular xanthoma, and clinicopathologic correlation is needed for separation from other non-Langerhans cell histiocytoses.
Show evidence (3 references)
PMID:12028152 SUPPORT Human clinical
"A series of 10 cases of PX was identified and the results compared with the other histologic subtypes, namely the polymorphous and the remaining other monomorphous reaction patterns in n-LCH."
Supports histologic comparison of monomorphous papular xanthoma against polymorphous and other non-Langerhans cell histiocytosis subtypes.
PMID:12028152 SUPPORT Human clinical
"Staining for factor XIIIa and CD1a were negative."
Documents negative factor XIIIa and CD1a staining in papular xanthoma, supporting immunohistochemical distinction from factor XIIIa-positive non-Langerhans cell histiocytoses such as juvenile xanthogranuloma.
PMID:28500693 SUPPORT Human clinical
"Among these, Langerhans cell histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma disseminatum, adult-onset xanthogranuloma, adult-onset asthma and periocular xanthogranuloma, necrobiotic xanthogranuloma,..."
Places juvenile xanthogranuloma alongside papular xanthoma in the differential diagnosis of normolipemic xanthomatous non-Langerhans cell histiocytoses.
Xanthelasma palpebrarum
Overlapping Features Eyelid xanthomatous lesions may resemble xanthelasma palpebrarum, but papular xanthoma belongs to the non-Langerhans cell histiocytosis group and requires biopsy-based distinction when eyelid lesions are atypical.
Distinguishing Features
  • Xanthelasma palpebrarum is the prototype localized eyelid xanthomatous lesion and may be associated with hyperlipidemia.
  • Papular xanthoma is listed among normolipemic non-Langerhans cell histiocytoses that can cause xanthomatous eyelid lesions.
Show evidence (2 references)
PMID:28500693 SUPPORT Human clinical
"The prototype is "xanthelasma palpebrarum" (XP) that is localized only to the eyelids and may be associated with hyperlipidemia."
This supports xanthelasma palpebrarum as the main eyelid xanthomatous comparator.
PMID:28500693 SUPPORT Human clinical
"Among these, Langerhans cell histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma disseminatum, adult-onset xanthogranuloma, adult-onset asthma and periocular xanthogranuloma, necrobiotic xanthogranuloma,..."
This explicitly places papular xanthoma among eyelid xanthomatous non-Langerhans histiocytosis differentials.
{ }

Source YAML

click to show 
name: Papular xanthoma
creation_date: "2026-05-07T23:30:22Z"
description: >
  Papular xanthoma is a rare cutaneous non-Langerhans cell histiocytosis in
  which papules are composed predominantly of xanthomatized macrophages. The
  classic clinicopathologic series frames it as a normolipemic skin-limited
  disorder, although pediatric exceptions with abnormal lipid profiles have
  been reported.
category: Rare Dermatologic Disorder
disease_term:
  preferred_term: Papular xanthoma
  term:
    id: MONDO:0015536
    label: papular xanthoma
parents:
- Non-Langerhans cell histiocytosis
- Cutaneous histiocytosis
synonyms:
- Papular xanthomatosis
classifications:
  harrisons_chapter:
  - classification_value: DERMATOLOGY
    notes: >-
      Papular xanthoma is a rare, skin-limited cutaneous non-Langerhans cell
      histiocytosis presenting with dermal xanthomatous papules.
    evidence:
    - reference: PMID:12028152
      reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Papular xanthoma (PX) is one of several clinicopathologic variants of
        normolipemic cutaneous non-Langerhans cell histiocytoses (n-LCH).
      explanation: >-
        Defines papular xanthoma as a cutaneous non-Langerhans cell
        histiocytosis of the skin, supporting placement in Harrison's
        dermatology Part.
    - reference: PMID:20199419
      reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Papular xanthoma is a rare normolipemic xanthomatous skin disease which
        primarily occurs in adults.
      explanation: >-
        Explicitly characterizes papular xanthoma as a xanthomatous skin
        disease.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: RARE
  notes: >-
    Population-level point prevalence is not established; papular xanthoma is a
    rare cutaneous non-Langerhans cell histiocytosis documented through small
    clinicopathologic series and isolated case reports, with a 4:1
    male-to-female ratio reported in the 10-case clinicopathologic study.
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this clinicopathologic study, papular xanthoma presented clinically
      mainly as solitary papule, with a male to female ratio of4 : 1, in an age
      range from 13 to 57 years and a biphasic occurrence: in the young
      adolescence and middle ages.
    explanation: >-
      Documents the 10-case clinicopathologic series and its 4:1 male-to-female
      distribution.
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This series confirms PX as a rare, but distinguished clinicopathologic
      entity in the spectrum of n-LCH of the skin.
    explanation: >-
      Confirms papular xanthoma as a rare entity within cutaneous
      non-Langerhans cell histiocytoses.
progression:
- phase: Biphasic adolescent and adult onset
  age_range: 13 to 57 years (young adolescence and middle age)
  notes: >-
    Papular xanthoma primarily occurs in adults, with the 10-case
    clinicopathologic series documenting an age range of 13 to 57 years and a
    biphasic distribution peaking in young adolescence and middle age.
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this clinicopathologic study, papular xanthoma presented clinically
      mainly as solitary papule, with a male to female ratio of4 : 1, in an age
      range from 13 to 57 years and a biphasic occurrence: in the young
      adolescence and middle ages.
    explanation: >-
      Establishes the 13 to 57 year age range and biphasic adolescent and
      middle-age distribution in the clinicopathologic series.
  - reference: PMID:20199419
    reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Papular xanthoma is a rare normolipemic xanthomatous skin disease which
      primarily occurs in adults.
    explanation: >-
      Confirms that papular xanthoma primarily presents in adulthood.
- phase: Childhood
  age_range: Childhood
  notes: >-
    Less commonly, papular xanthoma presents in children, including with
    multiple facial papules.
  evidence:
  - reference: PMID:20199419
    reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While this rare disorder has been documented in children, all but one
      reported in the literature had a normal lipid profile. We report a
      10-year-old girl with multiple papule xanthomas on her face that had an
      abnormal lipid profile.
    explanation: >-
      Documents childhood presentation with multiple facial papular xanthomas.
biochemical:
- name: Normal Serum Lipid Profile (Normolipemia)
  presence: Normal
  biomarker_term:
    preferred_term: cholesterol
    term:
      id: CHEBI:16113
      label: cholesterol
  loinc_term:
    id: LOINC:14647-2
    label: Cholesterol [Moles/volume] in Serum or Plasma
  context: >-
    Papular xanthoma is classically a normolipemic cutaneous non-Langerhans cell
    histiocytosis with normal serum cholesterol and triglyceride concentrations,
    distinguishing it from dyslipidemic cutaneous xanthomas.
  notes: >-
    Rare pediatric exceptions with abnormal serum lipid profiles have been
    documented (two pediatric cases noted by Alan Arbuckle and Prok 2010), so
    serum lipid evaluation remains part of the diagnostic workup.
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Papular xanthoma (PX) is one of several clinicopathologic variants of
      normolipemic cutaneous non-Langerhans cell histiocytoses (n-LCH).
    explanation: >-
      Defines papular xanthoma as a normolipemic cutaneous non-Langerhans cell
      histiocytosis.
  - reference: PMID:20199419
    reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While this rare disorder has been documented in children, all but one
      reported in the literature had a normal lipid profile. We report a
      10-year-old girl with multiple papule xanthomas on her face that had an
      abnormal lipid profile. To our knowledge this is only the second reported
      case of papular xanthoma in the pediatric population with an abnormal
      lipid profile.
    explanation: >-
      Confirms that normal serum lipid profiles are the rule in pediatric as
      well as adult papular xanthoma, while documenting the second reported
      pediatric case with an abnormal lipid profile.
  - reference: PMID:28500693
    reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      On the other hand, different types of normolipemic disorders may also
      cause xanthomatous eyelid lesions. Among these, Langerhans cell
      histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell
      histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma
      disseminatum, adult-onset xanthogranuloma, adult-onset asthma and
      periocular xanthogranuloma, necrobiotic xanthogranuloma, Erdheim-Chester
      disease, Rosai-Dorfman disease, and reticulohistiocytosis) can be listed.
    explanation: >-
      Places papular xanthoma among normolipemic disorders that cause
      xanthomatous lesions, contrasting it with hyperlipidemia-associated
      xanthelasma palpebrarum.
pathophysiology:
- name: Xanthomatized Dermal Macrophage Infiltration
  description: >
    Papular xanthoma lesions represent a monomorphous non-Langerhans cell
    histiocytosis reaction pattern dominated by xanthomatized macrophages in
    skin. Foamy macrophage accumulation and Touton giant cells produce the
    yellow papular clinical morphology and anchor the diagnosis histologically.
  cell_types:
  - preferred_term: xanthomatized macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: macrophage derived foam cell differentiation
    term:
      id: GO:0010742
      label: macrophage derived foam cell differentiation
  - preferred_term: lipid metabolic process
    term:
      id: GO:0006629
      label: lipid metabolic process
  downstream:
  - target: Solitary or multiple papules
    description: >
      Dermal xanthomatized macrophage accumulation produces the papular lesion
      morphology described clinically.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:12028152
      reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Histology showed moderately well circumscribed exoendophytic papules
        with a regular epidermis and a dense infiltration of xanthomatized
        macrophages interspersed by numerous Touton type giant cells.
      explanation: >-
        Connects the dense dermal infiltration of xanthomatized macrophages
        directly to the exoendophytic papular lesion morphology.
  - target: Yellow xanthomatous eyelid or periocular lesions
    description: >
      Xanthomatized macrophage infiltration in papular xanthoma is associated
      with xanthomatous lesions on the eyelids or periocular region.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:28500693
      reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        On the other hand, different types of normolipemic disorders may also
        cause xanthomatous eyelid lesions. Among these, Langerhans cell
        histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell
        histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma
        disseminatum, adult-onset xanthogranuloma, adult-onset asthma and
        periocular xanthogranuloma, necrobiotic xanthogranuloma, Erdheim-Chester
        disease, Rosai-Dorfman disease, and reticulohistiocytosis) can be
        listed.
      explanation: >-
        Lists papular xanthoma among normolipemic non-Langerhans cell
        histiocytoses that can cause xanthomatous eyelid lesions.
  - target: Foamy Xanthomatized Macrophage Infiltrate
    description: >
      The pathophysiologic macrophage accumulation is directly observed as the
      foamy or xanthomatized dermal infiltrate on biopsy.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:12028152
      reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        PX represents a monomorphous reaction pattern of n-LCH characterized by
        the presence of predominantly xanthomatized macrophages.
      explanation: >-
        Establishes that xanthomatized macrophage accumulation directly defines
        the monomorphous foamy macrophage infiltrate observed histopathologically.
  - target: Touton Giant Cells
    description: >
      Xanthomatous macrophage-rich lesions are histologically accompanied by
      Touton-type giant cells in the clinicopathologic series.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:12028152
      reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Histology showed moderately well circumscribed exoendophytic papules
        with a regular epidermis and a dense infiltration of xanthomatized
        macrophages interspersed by numerous Touton type giant cells.
      explanation: >-
        Documents the formation of numerous Touton type giant cells within the
        dense infiltration of xanthomatized macrophages in papular xanthoma
        lesions.
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PX represents a monomorphous reaction pattern of n-LCH characterized by
      the presence of predominantly xanthomatized macrophages.
    explanation: >
      The 10-case clinicopathologic series defines papular xanthoma as a
      non-Langerhans cell histiocytosis pattern dominated by xanthomatized
      macrophages.
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Histology showed moderately well circumscribed exoendophytic papules with
      a regular epidermis and a dense infiltration of xanthomatized macrophages
      interspersed by numerous Touton type giant cells.
    explanation: >
      This directly links the clinical papule to dense xanthomatized macrophage
      infiltration and Touton giant cells.
phenotypes:
- category: Dermatologic
  name: Solitary or multiple papules
  description: >
    Papular xanthoma presents as cutaneous papules, usually solitary in the
    adult clinicopathologic series but also reported as multiple facial papules
    in childhood.
  phenotype_term:
    preferred_term: Papule
    term:
      id: HP:0200034
      label: Papule
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this clinicopathologic study, papular xanthoma presented clinically
      mainly as solitary papule, with a male to female ratio of4 : 1, in an age
      range from 13 to 57 years and a biphasic occurrence: in the young
      adolescence and middle ages.
    explanation: >
      The series supports papules as the core clinical morphology and documents
      adolescent-to-adult presentations without using this as a frequency field.
  - reference: PMID:20199419
    reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a 10-year-old girl with multiple papule xanthomas on her face
      that had an abnormal lipid profile.
    explanation: >
      This pediatric case supports that papular xanthoma can present with
      multiple facial papules and that normolipemia is not absolute.
- category: Dermatologic
  name: Yellow xanthomatous eyelid or periocular lesions
  description: >
    Xanthomatous lesions can involve eyelid or periocular skin and must be
    distinguished from xanthelasma and other histiocytoses.
  phenotype_term:
    preferred_term: Yellow papule
    term:
      id: HP:0025507
      label: Yellow papule
  evidence:
  - reference: PMID:28500693
    reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      On the other hand, different types of normolipemic disorders may also
      cause xanthomatous eyelid lesions. Among these, Langerhans cell
      histiocytosis, diffuse normolipemic xanthoma, and non-Langerhans cell
      histiocytoses (papular xanthoma, juvenile xanthogranuloma, xanthoma
      disseminatum, adult-onset xanthogranuloma, adult-onset asthma and
      periocular xanthogranuloma, necrobiotic xanthogranuloma, Erdheim-Chester
      disease, Rosai-Dorfman disease, and reticulohistiocytosis) can be listed.
    explanation: >-
      Explicitly lists papular xanthoma among normolipemic non-Langerhans cell
      histiocytoses that cause xanthomatous eyelid lesions.
  - reference: PMID:21396554
    reference_title: "Periorbital lesions."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Histiocytosis is rare but does occur in prevalent locations."
    explanation: >
      This periorbital-lesion review supports that histiocytoses can occur
      around the eyes, but the abstract is not specific to papular xanthoma.
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was predominantly located on the trunk, the extremities, and rarely on the head."
    explanation: >
      This supports head involvement as a rare site in the clinicopathologic
      series, but only partially supports a periocular/head-involvement claim
      because the series emphasized trunk and extremity involvement.
histopathology:
- name: Foamy Xanthomatized Macrophage Infiltrate
  description: >
    Biopsy shows a circumscribed dermal papule with dense foamy or
    xanthomatized macrophages.
  finding_term:
    preferred_term: foamy macrophage
    term:
      id: HP:0025461
      label: Abnormal cell morphology
  diagnostic: true
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Histology showed moderately well circumscribed exoendophytic papules with
      a regular epidermis and a dense infiltration of xanthomatized macrophages
      interspersed by numerous Touton type giant cells.
    explanation: >
      This exact histologic description supports foamy/xanthomatized macrophage
      infiltrates as a diagnostic microscopic feature.
- name: Touton Giant Cells
  description: >
    Touton-type giant cells are commonly described in classic papular xanthoma
    histology and help place the lesion among xanthomatous histiocytoses. A
    precise HPO term for Touton giant cells was not found locally with OAK, and
    no finding_term is assigned; an HPO new term request may be needed.
  diagnostic: true
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Histology showed moderately well circumscribed exoendophytic papules with
      a regular epidermis and a dense infiltration of xanthomatized macrophages
      interspersed by numerous Touton type giant cells.
    explanation: >
      The series explicitly identifies numerous Touton-type giant cells in
      papular xanthoma histology.
diagnosis:
- name: Skin biopsy with histology and immunohistochemistry
  description: >
    Diagnosis is established by biopsy demonstrating xanthomatized macrophages
    and Touton giant cells, with immunohistochemistry supporting a
    non-Langerhans macrophage lineage.
  diagnosis_term:
    preferred_term: biopsy of skin
    term:
      id: NCIT:C51692
      label: Skin Biopsy
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      OBJECTIVE: The purpose of this study was to identify the clinical,
      histological and immunohistochemical characteristics of PX.
    explanation: >
      The foundational series used clinicopathologic, histologic, and
      immunohistochemical characterization to define papular xanthoma.
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Immunohistochemically mono- and multinucleated macrophages were
      consistently positive with KiM1p; while only giant cells were labeled with
      KP1 (CD68), the reactivity with HAM 56 was much more variable.
    explanation: >
      This supports immunohistochemistry as part of diagnostic confirmation and
      documents macrophage marker reactivity.
- name: Immunohistochemical macrophage marker profile
  description: >
    Papular xanthoma immunohistochemistry supports non-Langerhans macrophage
    lineage: mono- and multinucleated macrophages are KiM1p-positive, Touton
    giant cells are KP1/CD68-positive, and factor XIIIa and CD1a are negative.
  diagnosis_term:
    preferred_term: immunohistochemistry
    term:
      id: NCIT:C23020
      label: Immunohistochemistry Staining Method
  markers: "KiM1p positive; KP1/CD68 positive in giant cells; factor XIIIa negative; CD1a negative"
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Immunohistochemically mono- and multinucleated macrophages were
      consistently positive with KiM1p; while only giant cells were labeled with
      KP1 (CD68), the reactivity with HAM 56 was much more variable.
    explanation: >
      This documents KiM1p positivity in mono- and multinucleated macrophages
      and KP1/CD68 labeling in Touton-type giant cells.
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Staining for factor XIIIa and CD1a were negative."
    explanation: >
      This documents the negative factor XIIIa and CD1a components of the
      diagnostic immunohistochemical profile.
- name: Lipid and systemic evaluation
  description: >
    Papular xanthoma is classically normolipemic, but lipid testing is still
    clinically relevant because abnormal pediatric lipid profiles have been
    reported and eyelid xanthomatous lesions may overlap with systemic
    disorders.
  evidence:
  - reference: PMID:20199419
    reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Papular xanthoma is a rare normolipemic xanthomatous skin disease which
      primarily occurs in adults.
    explanation: >
      This supports normolipemia as the classic framing of papular xanthoma.
  - reference: PMID:20199419
    reference_title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While this rare disorder has been documented in children, all but one
      reported in the literature had a normal lipid profile.
    explanation: >
      This supports lipid-profile evaluation and shows that normal lipids are
      usual but not universal in reported pediatric disease.
differential_diagnoses:
- name: Juvenile xanthogranuloma
  description: >
    Juvenile xanthogranuloma is the key clinical and histopathologic mimic,
    especially in infants and children with multiple yellow papules.
  distinguishing_features:
  - Papular xanthoma is modeled as a more monomorphous xanthomatized macrophage pattern.
  - Factor XIIIa staining is negative in papular xanthoma, and clinicopathologic correlation is needed for separation from other non-Langerhans cell histiocytoses.
  evidence:
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A series of 10 cases of PX was identified and the results compared with
      the other histologic subtypes, namely the polymorphous and the remaining
      other monomorphous reaction patterns in n-LCH.
    explanation: >-
      Supports histologic comparison of monomorphous papular xanthoma against
      polymorphous and other non-Langerhans cell histiocytosis subtypes.
  - reference: PMID:12028152
    reference_title: "Papular xanthoma: a clinicopathological study of 10 cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Staining for factor XIIIa and CD1a were negative."
    explanation: >-
      Documents negative factor XIIIa and CD1a staining in papular xanthoma,
      supporting immunohistochemical distinction from factor XIIIa-positive
      non-Langerhans cell histiocytoses such as juvenile xanthogranuloma.
  - reference: PMID:28500693
    reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among these, Langerhans cell histiocytosis, diffuse normolipemic xanthoma,
      and non-Langerhans cell histiocytoses (papular xanthoma, juvenile
      xanthogranuloma, xanthoma disseminatum, adult-onset xanthogranuloma,
      adult-onset asthma and periocular xanthogranuloma, necrobiotic
      xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease, and
      reticulohistiocytosis) can be listed.
    explanation: >-
      Places juvenile xanthogranuloma alongside papular xanthoma in the
      differential diagnosis of normolipemic xanthomatous non-Langerhans cell
      histiocytoses.
- name: Xanthelasma palpebrarum
  description: >
    Eyelid xanthomatous lesions may resemble xanthelasma palpebrarum, but
    papular xanthoma belongs to the non-Langerhans cell histiocytosis group and
    requires biopsy-based distinction when eyelid lesions are atypical.
  distinguishing_features:
  - Xanthelasma palpebrarum is the prototype localized eyelid xanthomatous lesion and may be associated with hyperlipidemia.
  - Papular xanthoma is listed among normolipemic non-Langerhans cell histiocytoses that can cause xanthomatous eyelid lesions.
  evidence:
  - reference: PMID:28500693
    reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prototype is "xanthelasma palpebrarum" (XP) that is localized only to
      the eyelids and may be associated with hyperlipidemia.
    explanation: >
      This supports xanthelasma palpebrarum as the main eyelid xanthomatous
      comparator.
  - reference: PMID:28500693
    reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among these, Langerhans cell histiocytosis, diffuse normolipemic xanthoma,
      and non-Langerhans cell histiocytoses (papular xanthoma, juvenile
      xanthogranuloma, xanthoma disseminatum, adult-onset xanthogranuloma,
      adult-onset asthma and periocular xanthogranuloma, necrobiotic
      xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease, and
      reticulohistiocytosis) can be listed.
    explanation: >
      This explicitly places papular xanthoma among eyelid xanthomatous
      non-Langerhans histiocytosis differentials.
treatments:
- name: Observation and supportive follow-up
  description: >
    No disease-specific standard pharmacotherapy is established in the fetched
    abstracts. Management is therefore represented conservatively as supportive
    follow-up after diagnosis, lipid evaluation, and assessment for systemic or
    associated disorders when clinically indicated.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:28500693
    reference_title: "The clinical spectrum of xanthomatous lesions of the eyelids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      It is necessary to obtain a thorough history and exclude XP and then
      perform detailed dermatological and systemic examination, biopsy for
      histopathologic confirmation, and appropriate specific imaging screens.
    explanation: >
      This supports careful diagnostic evaluation and follow-up for
      xanthomatous eyelid lesions, but it is not a papular-xanthoma-specific
      treatment trial.
references:
- reference: PMID:12028152
  title: "Papular xanthoma: a clinicopathological study of 10 cases."
- reference: PMID:20199419
  title: "Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile."
- reference: PMID:28500693
  title: "The clinical spectrum of xanthomatous lesions of the eyelids."
- reference: PMID:21396554
  title: "Periorbital lesions."
- reference: PMID:35637637
  title: "Multiple papular xanthomas mimicking juvenile xanthogranulomas in an infant: A case report and review of the literature."
notes: >-
  Falcon deep research identified additional case reports and treatment comments,
  but several cited DOI caches had no fetchable abstract content. Claims here are
  limited to snippets available from fetched PMID/DOI caches. In classifications,
  harrisons_chapter is set to DERMATOLOGY; mechanistic_category is omitted
  because no MechanisticNosologyEnum value covers non-Langerhans cell
  histiocytoses, and icdo_morphology is omitted because papular xanthoma is
  characterized in the foundational clinicopathologic series (PMID:12028152) as a
  monomorphous cutaneous reaction pattern rather than a clonal histiocytic
  neoplasm. No Mendelian inheritance or germline causal gene is established for
  sporadic papular xanthoma.
📚

References & Deep Research

References

5
PMID:12028152
Papular xanthoma: a clinicopathological study of 10 cases.
No top-level findings curated for this source.
PMID:20199419
Case report--papular xanthoma in a 10-year-old female with abnormal lipid profile.
No top-level findings curated for this source.
PMID:28500693
The clinical spectrum of xanthomatous lesions of the eyelids.
No top-level findings curated for this source.
PMID:21396554
Periorbital lesions.
No top-level findings curated for this source.
PMID:35637637
Multiple papular xanthomas mimicking juvenile xanthogranulomas in an infant: A case report and review of the literature.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Record notes

Falcon deep research identified additional case reports and treatment comments, but several cited DOI caches had no fetchable abstract content. Claims here are limited to snippets available from fetched PMID/DOI caches. In classifications, harrisons_chapter is set to DERMATOLOGY; mechanistic_category is omitted because no MechanisticNosologyEnum value covers non-Langerhans cell histiocytoses, and icdo_morphology is omitted because papular xanthoma is characterized in the foundational clinicopathologic series (PMID:12028152) as a monomorphous cutaneous reaction pattern rather than a clonal histiocytic neoplasm. No Mendelian inheritance or germline causal gene is established for sporadic papular xanthoma.

Falcon ▸
Papular Xanthoma (PX) — Comprehensive Disease Characteristics Report
Edison Scientific Literature 20 citations 2026-05-07T19:41:35.190634

Papular Xanthoma (PX) — Comprehensive Disease Characteristics Report

Target disease

  • Disease name: Papular xanthoma (PX)
  • Category: Rare dermatologic disorder; cutaneous non‑Langerhans cell histiocytosis (xanthomatous)
  • MONDO / Orphanet / OMIM / MeSH / ICD identifiers: Not available in the retrieved full-text sources used for this report; should be obtained from MONDO/Orphanet/ICD/MeSH databases in a separate curation step.

Evidence base and recency note

Papular xanthoma is very rare and much of the literature consists of case reports/series. The most directly informative recent source retrieved here is a 2023 case report with literature review (Journal of Cutaneous Pathology, May 2023). Several key clinicopathologic facts come from a foundational 10‑case series (2002) and pediatric case reports (2010–2020). (francois2023multiplepapularxanthomas pages 2-2, breier2002papularxanthomaa pages 1-2, ramessur2020eruptivepapulesin pages 1-2)

PMID note: PMIDs were not present in the retrieved text extracts; therefore this report cites DOI/URLs and the tool-provided context IDs.

1. Disease information

1.1 Overview (what is the disease?)

Papular xanthoma (PX) is a rare, primarily cutaneous, xanthomatous lesion characterized by a dermal proliferation/infiltrate of lipid-laden (“foamy”) histiocytes/macrophages, typically occurring with normal serum lipid profiles (normolipemic) and classified among cutaneous non‑Langerhans cell histiocytoses. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, breier2002papularxanthomaa pages 1-2)

1.2 Synonyms / alternative names

  • “Papular xanthoma” (primary term)
  • “Papular xanthomatosis” is used in some contexts for papular xanthoma presentations (as reflected in older terminology and diagnostic criteria discussions). (ramessur2020eruptivepapulesin pages 1-2, breier2002papularxanthomaa pages 1-2)

1.3 Evidence source type

The current understanding is derived predominantly from aggregated disease-level literature (case series and reviews) plus individual patient case reports, rather than EHR-scale evidence. (breier2002papularxanthomaa pages 2-4, francois2023multiplepapularxanthomas pages 2-2, ramessur2020eruptivepapulesin pages 1-2)

1.4 Key recent and authoritative sources (publication date; URL)

  • Francois et al. “Multiple papular xanthomas mimicking juvenile xanthogranulomas in an infant: A case report and review of the literature.” May 2023. https://doi.org/10.1111/cup.14244 (francois2023multiplepapularxanthomas pages 2-2)
  • Breier et al. “Papular xanthoma: a clinicopathological study of 10 cases.” Apr 2002. https://doi.org/10.1034/j.1600-0560.2002.290402.x (breier2002papularxanthomaa pages 1-2)
  • Ramessur et al. “Eruptive papules in a 4-year-old girl” (Diagnosis: papular xanthoma). Jan 2020. https://doi.org/10.1111/pde.14023 (ramessur2020eruptivepapulesin pages 1-2)
  • Baykal et al. “The clinical spectrum of xanthomatous lesions of the eyelids.” May 2017. https://doi.org/10.1111/ijd.13637 (baykal2017theclinicalspectrum pages 1-2)

2. Etiology

2.1 Disease causal factors

No single genetic cause or infectious agent was identified in the retrieved literature excerpts. PX is framed as a clinicopathologic entity within non‑Langerhans cell histiocytoses, defined by a macrophage/foam-cell infiltrate pattern rather than a known monogenic defect. (breier2002papularxanthomaa pages 2-4, breier2002papularxanthomaa pages 1-2)

2.2 Risk factors

  • Age: PX occurs in both children and adults; adult disease may show a biphasic pattern (adolescence and middle age) in the 10-case series. (breier2002papularxanthomaa pages 1-2)
  • Lipid dysregulation (possible, not required): Although PX is classically normolipemic, exceptions exist. Pediatric cases with abnormal lipid profiles have been reported and authors argue lipid criteria may need reevaluation. (arbuckle2010casereport—papularxanthoma pages 1-3, ramessur2020eruptivepapulesin pages 1-2)

2.3 Protective factors

No protective genetic or environmental factors were identified in the retrieved sources.

2.4 Gene–environment interactions

No gene–environment interaction evidence was identified in the retrieved sources.

3. Phenotypes

3.1 Cutaneous phenotypes (symptoms/signs)

Core phenotype: Asymptomatic yellow/yellow‑brown papules (sometimes papulonodules), often widespread; may be solitary or disseminated. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2)

Distribution: - Adult series: trunk and extremities predominated; head less common; most were solitary lesions (9/10). (breier2002papularxanthomaa pages 1-2) - Pediatric PX: often head, trunk, extremities with sparing of mucosa, palms, soles, and generally flexures (except axillae), though presentations vary. (ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2)

Periorbital/eyelid involvement: PX can present with yellowish papulonodular lesions “often located around the eyes” in periorbital lesion reviews; eyelid involvement is illustrated in an eyelid-focused review of xanthomatous lesions. (rebora2011periorbitallesions. pages 4-5, baykal2017theclinicalspectrum pages 1-2)

3.2 Laboratory abnormalities

  • Classically normal lipid profile is part of diagnostic criteria, but not universal. (ramessur2020eruptivepapulesin pages 1-2, arbuckle2010casereport—papularxanthoma pages 1-3)
  • Example pediatric workup with normal lipids and other labs: CBC, LFTs, TFTs, immunoglobulins, serum protein electrophoresis (SPEP), and imaging (liver/spleen ultrasound) all normal in one case. (ramessur2020eruptivepapulesin pages 1-2)

3.3 Phenotype characteristics (onset/severity/progression/frequency)

  • Childhood onset: In pediatric cases, onset is reported in the first year of life in ~90% and most regress within five years. (ramessur2020eruptivepapulesin pages 1-2)
  • Course: Childhood PX is typically self‑limited; adult PX may be more persistent/progressive. (choudhary2015papularxanthomain pages 1-2, francois2023multiplepapularxanthomas pages 2-2)
  • Residual changes: “Anetoderma-like scars” after resolution reported in up to 60% of pediatric cases. (ramessur2020eruptivepapulesin pages 1-2)

3.4 Quality of life impact

Formal QoL instruments (e.g., DLQI, PROMIS) were not reported in the retrieved sources. The main impacts described are cosmetic burden and potential residual atrophic/hyperpigmented scarring after lesion regression in children. (ramessur2020eruptivepapulesin pages 1-2)

3.5 Suggested HPO terms (phenotype encoding)

(These are suggested mappings based on described clinical findings; ontology IDs should be verified during curation.) - Yellow papules / xanthomatous papules → Xanthoma; Skin papule (ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2) - Periorbital distribution → Periorbital skin lesion (rebora2011periorbitallesions. pages 4-5) - Post-inflammatory hyperpigmentation / residual hyperpigmented macules → Hyperpigmentation of the skin (ramessur2020eruptivepapulesin pages 1-2) - Atrophic/anethoderma-like scarring → Atrophic scar / Anetoderma (ramessur2020eruptivepapulesin pages 1-2)

4. Genetic/Molecular information

4.1 Causal genes

No causal genes or recurrent pathogenic variants were identified in the retrieved PX evidence.

4.2 Molecular/cellular identity (immunophenotype)

PX lesions show a macrophage/histiocyte immunophenotype: - CD68 positive histiocytes are typical. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2) - S100 negative and CD1a negative are repeatedly reported, supporting non‑Langerhans lineage. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2) - Factor XIIIa (FXIIIa): variable across reports—positive in at least one pediatric case report and negative in the 10-case adult series and in an infant case review; this variability is important for differential diagnosis with juvenile xanthogranuloma and related entities. (ramessur2020eruptivepapulesin pages 1-2, breier2002papularxanthomaa pages 1-2, francois2023multiplepapularxanthomas pages 2-2)

4.3 Suggested GO/CL terms (mechanistic annotation)

(Conceptual mapping consistent with lesion composition; requires ontology verification.) - CL: macrophage / histiocyte (dominant foamy cells) (breier2002papularxanthomaa pages 2-4, breier2002papularxanthomaa pages 1-2) - GO Biological Process: lipid metabolic process / foam cell differentiation (inferred from “xanthomatized/foamy” macrophages; mechanistic detail not experimentally established for PX in these sources) (breier2002papularxanthomaa pages 2-4)

5. Environmental information

No specific toxins, occupational exposures, lifestyle factors, or infectious triggers were established as causal. Some case-based associations have been reported with inflammatory/eruptive contexts (viral/drug eruptions) but without mechanistic proof. (ramessur2020eruptivepapulesin pages 1-2)

6. Mechanism / Pathophysiology

6.1 Current understanding

PX is best understood as a localized cutaneous accumulation/proliferation of lipid-laden macrophages in the dermis, producing yellow papules/nodules. Histologically it is typically well delimited with dense infiltrates of xanthomatized cells and variable Touton giant cells, and with relative absence of inflammatory cells and lack of an early “primitive histiocytic” phase in classic descriptions. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2)

6.2 Relationship to juvenile xanthogranuloma (JXG)

PX is repeatedly emphasized as a key histopathologic/clinical mimic of JXG; some authors consider PX within a spectrum/variant of xanthogranuloma (xanthomatous pattern). (francois2023multiplepapularxanthomas pages 2-2, ramessur2020eruptivepapulesin pages 1-2)

6.3 Evidence gaps

No pathway-level (e.g., MAPK, PI3K-AKT) or omics profiling findings (transcriptomics/proteomics) were identified in the retrieved PX sources.

7. Anatomical structures affected

7.1 Organ and tissue level

  • Primary: Skin—dermis (papillary/reticular dermis depending on case). (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2)
  • Sites: trunk, extremities, head/neck; periorbital/eyelid region in some patients. (breier2002papularxanthomaa pages 1-2, rebora2011periorbitallesions. pages 4-5, baykal2017theclinicalspectrum pages 1-2)

7.2 Cell types (Cell Ontology suggestions)

  • Foamy histiocytes/macrophages (dominant infiltrate). (breier2002papularxanthomaa pages 2-4, breier2002papularxanthomaa pages 1-2)

7.3 Subcellular/localization (GO CC suggestions)

Not directly studied in retrieved sources; lipid-laden/foamy cytoplasm implies lipid droplets/lysosomal compartments, but this remains inferential here.

7.4 UBERON suggestions

  • Skin of trunk/limb regions; periorbital skin/eyelid skin (verify exact UBERON terms during curation). (breier2002papularxanthomaa pages 1-2, rebora2011periorbitallesions. pages 4-5)

8. Temporal development

8.1 Onset

  • Children: commonly within the first year of life (~90% in pediatric descriptions), but later onset can occur (example onset at age 3 years). (ramessur2020eruptivepapulesin pages 1-2)
  • Adults: series shows onset across adolescence to middle age with biphasic occurrence. (breier2002papularxanthomaa pages 1-2)

8.2 Progression/course

  • Pediatric disease often flattens and regresses over years, leaving transient hyperpigmentation and sometimes anetoderma-like scars. (ramessur2020eruptivepapulesin pages 1-2)
  • Adults may have more persistent/progressive or recurrent lesions per literature summaries. (francois2023multiplepapularxanthomas pages 2-2, choudhary2015papularxanthomain pages 1-2)

9. Inheritance and population

9.1 Epidemiology

No population prevalence/incidence estimates were found in retrieved sources.

Case-count statistics from reviews/series: - 2002 clinicopathologic series noted: “Until now, 43 cases of cutaneous PX have been described” (at that time). (breier2002papularxanthomaa pages 2-4) - 2023 literature review summary cited ~53–54 patients reported across ~22 reports, and that 18 had follow-up (median 28 months; mean 41.3 months) with 2 recurrent/persistent lesions. (francois2023multiplepapularxanthomas pages 2-2, francois2023multiplepapularxanthomas pages 2-3)

9.2 Inheritance

No inheritance pattern is established in the retrieved literature. A family history of hypercholesterolemia was noted in one pediatric PX case, but causality/inheritance specific to PX was not established. (ramessur2020eruptivepapulesin pages 1-2)

10. Diagnostics

10.1 Clinical criteria

Winkelmann’s PX diagnostic criteria (as reproduced in a pediatric diagnostic case discussion) include: 1) generalized asymptomatic yellowish papulonodular lesions without coalescing plaques, 2) normal lipid profile, 3) no visceral involvement, 4) foamy-cell predominant infiltrate, 5) absence of primitive histiocytic phase and inflammatory cells. (ramessur2020eruptivepapulesin pages 1-2)

10.2 Histopathology

Typical biopsy features include a well-delimited dermal tumor/infiltrate with a small grenz zone and dense infiltrate of foamy/xanthomatized histiocytes with numerous Touton-type giant cells (though Touton cells may be absent in some pediatric lesions). (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2)

10.3 Immunohistochemistry

Common IHC profile: - CD68+ histiocytes (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2) - S100−, CD1a− (helps exclude Langerhans cell histiocytosis) (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2) - FXIIIa: may be positive or negative depending on case/series; therefore should not be used as a sole discriminator. (ramessur2020eruptivepapulesin pages 1-2, breier2002papularxanthomaa pages 1-2, francois2023multiplepapularxanthomas pages 2-2)

10.4 Recommended workup (real-world practice)

From case reports and eyelid review guidance, commonly implemented evaluation includes: - Fasting lipid profile (including repeat testing if abnormal) (arbuckle2010casereport—papularxanthoma pages 1-3, ramessur2020eruptivepapulesin pages 1-2) - Screening for systemic disease/visceral involvement (e.g., ultrasound imaging in pediatric cases; chest X-ray in one report) (ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2) - Additional labs sometimes used: serum protein electrophoresis (SPEP) (arbuckle2010casereport—papularxanthoma pages 1-3) - Biopsy with histopathologic confirmation and IHC (ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2) - For xanthomatous eyelid lesions broadly: obtain history, exclude xanthelasma palpebrarum, detailed derm/systemic exam, biopsy, and “appropriate specific imaging screens.” (baykal2017theclinicalspectrum pages 1-2)

10.5 Differential diagnosis (key discriminators)

  • Juvenile xanthogranuloma (JXG): key mimic; PX is more monomorphic/foamy and lacks prominent inflammatory milieu/primitive histiocytic phase described for JXG in classic teaching. (ramessur2020eruptivepapulesin pages 1-2, francois2023multiplepapularxanthomas pages 2-2)
  • Xanthoma disseminatum (XD): differentiated clinically by plaque tendency, flexural involvement, diabetes insipidus/mucosal involvement (in XD), and by histologic inflammatory features. (ramessur2020eruptivepapulesin pages 1-2)
  • Benign cephalic histiocytosis: considered in facial-limited pediatric case; distinguished histologically (BCH lacks lipid-laden histiocytes). (arbuckle2010casereport—papularxanthoma pages 1-3)
  • Other clinical misdiagnoses reported: xanthoma, atheroma, keloid, histiocytoma, Spitz nevus, clear cell acanthoma, perioral dermatitis. (breier2002papularxanthomaa pages 2-4, breier2002papularxanthomaa pages 1-2, arbuckle2010casereport—papularxanthoma pages 1-3)

11. Outcome / Prognosis

11.1 Overall prognosis

  • Children: typically favorable with spontaneous regression over years; a case followed for 3 years showed progressive reduction in lesions and residual atrophic hyperpigmented macules. (ramessur2020eruptivepapulesin pages 1-2)
  • Adults: more likely to persist, recur, or associate with systemic disease per 2023 review summary. (francois2023multiplepapularxanthomas pages 2-2)

11.2 Complications

  • Residual anetoderma-like scarring (up to 60% in pediatric descriptions) and hyperpigmentation are notable cutaneous sequelae. (ramessur2020eruptivepapulesin pages 1-2)

12. Treatment

12.1 Current management (real-world implementation)

  • Observation / expectant management is commonly used in children because lesions are self-limiting. (choudhary2015papularxanthomain pages 1-2)
  • There is no consistently effective standard therapy established for adults in the retrieved excerpts. (choudhary2015papularxanthomain pages 1-2, francois2023multiplepapularxanthomas pages 2-2)

12.2 Reported therapies

  • One pediatric report notes an adult case report of PX “resolved satisfactorily with doxycycline” (secondary mention; primary adult doxycycline paper not retrieved here). (choudhary2015papularxanthomain pages 1-2)

12.3 MAXO (treatment ontology) suggestions

(Require MAXO ID verification during curation.) - Watchful waiting / observation (pediatric) (choudhary2015papularxanthomain pages 1-2) - Skin biopsy (diagnostic procedure; also a medical action) (ramessur2020eruptivepapulesin pages 1-2) - Systemic antibiotic therapy (doxycycline) — only case-level mention (choudhary2015papularxanthomain pages 1-2)

13. Prevention

No primary prevention strategies are established. Practical prevention is limited to addressing modifiable lipid abnormalities if present and monitoring for associated conditions when clinically indicated. (arbuckle2010casereport—papularxanthoma pages 1-3, ramessur2020eruptivepapulesin pages 1-2)

14. Other species / natural disease

No naturally occurring PX analog in non-human species was identified in the retrieved sources.

15. Model organisms

No PX-specific model organisms or induced experimental models were identified in the retrieved sources.

Recent developments and expert-style synthesis (2023–2024 emphasis)

Key 2023 insights

The 2023 case report with literature review consolidates modern understanding that PX can mimic JXG clinically and histologically, provides updated case counts (~53–54 total patients), and emphasizes age-dependent natural history (self-limited in many pediatric cases vs persistence/recurrence and systemic associations more often discussed in adults). (francois2023multiplepapularxanthomas pages 2-2, francois2023multiplepapularxanthomas pages 2-3)

Authoritative clinical perspective (workup and caution)

Eyelid-focused review literature emphasizes that xanthomatous periocular lesions can reflect a spectrum of disorders, some with systemic/malignancy associations, and recommends thorough history, systemic examination, biopsy confirmation, and appropriate imaging when evaluating these presentations. (baykal2017theclinicalspectrum pages 1-2)

Summary tables

The following evidence-map table consolidates the most actionable facts for knowledge base population.

Clinical domain Key facts Quantitative details Evidence
Definition / classification Papular xanthoma (PX) is a rare normolipemic cutaneous non-Langerhans cell histiocytosis and a monomorphous xanthomatized macrophage-predominant reaction pattern within the n-LCH spectrum. It was originally defined by Winkelmann as a distinct xanthogranulomatous/xanthomatous entity. Largest older clinicopathologic series: 10 cases. (breier2002papularxanthomaa pages 1-2, breier2002papularxanthomaa pages 2-4)
Lipid profile status PX is classically described as normolipemic, and diagnostic criteria include a normal lipid profile and no visceral involvement. However, exceptions have been reported, including pediatric cases with lipid abnormalities and historical association with dysbetalipoproteinemia, suggesting the criterion is not absolute. In one pediatric case, triglycerides were 334 mg/dL initially and 241 mg/dL on repeat fasting test; cholesterol 134 mg/dL then 145 mg/dL. (ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2, arbuckle2010casereport—papularxanthoma pages 1-3)
Age of onset patterns PX occurs in both children and adults. Adult series showed a biphasic occurrence in adolescence and middle age. Pediatric disease usually starts in the first year of life, but later childhood onset also occurs. Adult series age range 13-57 years; pediatric onset in ~90% during the first year of life; one case began at age 3 years, another at 4.5 years, another at 10 years. (breier2002papularxanthomaa pages 1-2, ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2, arbuckle2010casereport—papularxanthoma pages 1-3)
Distribution / anatomic sites Lesions are typically yellow to yellow-brown papules/nodules, often on trunk and extremities; head/neck involvement can occur. Pediatric cases often involve head, trunk, and extremities with sparing of mucosa, palms, soles, and usually flexures. Eyelid/periorbital involvement is documented and may appear as flat plaques or papulonodular xanthomatous lesions. In the 10-case series, trunk was most common (50%); 9/10 were solitary and 1/10 disseminated. (breier2002papularxanthomaa pages 1-2, ramessur2020eruptivepapulesin pages 1-2, francois2023multiplepapularxanthomas pages 2-2, choudhary2015papularxanthomain pages 1-2, baykal2017theclinicalspectrum pages 4-6, baykal2017theclinicalspectrum pages 1-2, rebora2011periorbitallesions. pages 4-5)
Histopathology PX shows a well-delimited dermal infiltrate of foamy/xanthomatized histiocytes/macrophages, often with Touton giant cells, a relative absence of inflammatory cells, and no primitive histiocytic phase. Pediatric lesions may lack giant cells and remain monomorphic. Some childhood cases show no multinucleated/Touton giant cells; others show moderate/numerous Touton cells. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, francois2023multiplepapularxanthomas pages 2-2, francois2023multiplepapularxanthomas pages 2-3, ramessur2020eruptivepapulesin pages 2-2, breier2002papularxanthomaa pages 1-2, choudhary2015papularxanthomain pages 1-2)
Immunohistochemistry PX usually shows CD68 positivity and is typically S100-negative and CD1a-negative. Factor XIIIa findings are variable across reports: negative in the 10-case adult series and some recent infant data, but positive in at least one pediatric case. In the 2002 series, KiM1p was consistently positive; KP1/CD68 labeled mainly giant cells; HAM56 was variable. Marker pattern summary: CD68+, S100-, CD1a-; FXIIIa variable; KiM1p+ in the adult series. (breier2002papularxanthomaa pages 1-2, breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, francois2023multiplepapularxanthomas pages 2-2, francois2023multiplepapularxanthomas pages 2-3, choudhary2015papularxanthomain pages 1-2)
Key differential diagnoses Important differentials include juvenile xanthogranuloma (JXG), xanthoma disseminatum (XD), benign cephalic histiocytosis (BCH), Spitz nevus, clear cell acanthoma, xanthoma, atheroma, keloid, histiocytoma, and in some facial cases granulomatous/perioral dermatitis. Distinguishing features rely on biopsy and immunophenotype. JXG is the principal histopathologic mimic; PX differs by monomorphic foamy-cell infiltrate and relative lack of inflammatory cells/primitive phase. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, francois2023multiplepapularxanthomas pages 2-2, choudhary2015papularxanthomain pages 1-2, breier2002papularxanthomaa pages 1-2, arbuckle2010casereport—papularxanthoma pages 1-3)
Reported associations PX is usually isolated, but reported associations include mycosis fungoides, Sezary syndrome, later CD3(dim)/CD4+ T-cell lymphoma, dysbetalipoproteinemia, erythrodermic chronic actinic dermatitis, and viral/drug eruptions. Systemic associations remain uncertain overall. Eyelid review documented at least one patient with PX plus mycosis fungoides. (ramessur2020eruptivepapulesin pages 1-2, choudhary2015papularxanthomain pages 1-2, ramessur2020eruptivepapulesin pages 2-2, baykal2017theclinicalspectrum pages 4-6, baykal2017theclinicalspectrum pages 1-2)
Natural history / prognosis Childhood PX is generally self-limited, with lesion flattening and residual hyperpigmentation or anetoderma-like change; adults may show persistent, progressive, or recurrent disease. Observation is typical in children. Childhood lesions often regress within 1-5 years; most regress within 5 years; anetoderma-like scarring reported in up to 60%; one child had improvement over 3 years with no new lesions. (breier2002papularxanthomaa pages 2-4, ramessur2020eruptivepapulesin pages 1-2, francois2023multiplepapularxanthomas pages 2-2, choudhary2015papularxanthomain pages 1-2, ramessur2020eruptivepapulesin pages 2-2)
Epidemiology / case counts PX is very rare, with literature estimates differing by review date and inclusion criteria. Older and newer reviews consistently indicate only a few dozen documented patients. Older review: 43 cutaneous cases before the 2002 series; 2023 review states 53 reported patients with 35 in four comprehensive series and 18 with follow-up (median 28 months, mean 41.3 months); another 2023 summary states 22 reports / 54 patients. (breier2002papularxanthomaa pages 2-4, francois2023multiplepapularxanthomas pages 2-2, francois2023multiplepapularxanthomas pages 2-3, breier2002papularxanthomaa pages 1-2)
Suggested workup from reported practice Reported evaluation includes fasting lipid profile, CBC/basic labs, serum protein electrophoresis, assessment for visceral/systemic involvement, skin biopsy with histology and immunohistochemistry, and when periocular disease is present, broader dermatologic/systemic assessment. Pediatric workups included normal abdominal ultrasound/chest X-ray in one case and normal liver/spleen ultrasound in another. (ramessur2020eruptivepapulesin pages 1-2, arbuckle2010casereport—papularxanthoma pages 1-3, choudhary2015papularxanthomain pages 1-2, baykal2017theclinicalspectrum pages 1-2)

Table: This table compiles the main clinically actionable facts about papular xanthoma from the provided evidence, including phenotype, pathology, immunohistochemistry, associations, prognosis, and reported case statistics. It is useful as a compact evidence map for building a disease knowledge base entry.

Key evidence-supported “abstract-quote” style statements (verbatim from retrieved texts)

  • Pediatric PX course statistics: “In 90% of cases, the skin lesions have their onset during the first year of life and most regress within five years.” (ramessur2020eruptivepapulesin pages 1-2)
  • Pediatric sequelae: “Anetoderma-like scars have been reported after resolution of lesions in up to 60% of cases.” (ramessur2020eruptivepapulesin pages 1-2)
  • 2002 rarity estimate: “Until now, 43 cases of cutaneous PX have been described …” (breier2002papularxanthomaa pages 2-4)
  • Periorbital location statement: “Papular xanthoma is a rare entity characterized by yellowish papulonodular lesions, clinically indistinguishable from those of juvenile xanthogranuloma, often located around the eyes.” (rebora2011periorbitallesions. pages 4-5)

Limitations of this report

  • Formal disease identifiers (MONDO/Orphanet/ICD/MeSH/OMIM) and PMIDs were not present in the retrieved excerpts and therefore could not be cited here.
  • Genetics/omics/pathway-level mechanisms for PX were not found in the retrieved corpus.
  • Treatment evidence is limited mainly to observation in children and sparse case-level reports; no clinical trials were identified.

References

  1. (francois2023multiplepapularxanthomas pages 2-2): Rony A. Francois, Grant J. Randall, Eric W. Rudnick, Stephanie J. Carstens, and Vladimir Vincek. Multiple papular xanthomas mimicking juvenile xanthogranulomas in an infant: a case report and review of the literature. Journal of Cutaneous Pathology, 50:1-7, May 2023. URL: https://doi.org/10.1111/cup.14244, doi:10.1111/cup.14244. This article has 0 citations and is from a peer-reviewed journal.

  2. (breier2002papularxanthomaa pages 1-2): Friedrich Breier, Bettina Zelger, Harald Reiter, Friedrich Gschnait, and Bernhard W. H. Zelger. Papular xanthoma: a clinicopathological study of 10 cases. Journal of Cutaneous Pathology, 29:200-206, Apr 2002. URL: https://doi.org/10.1034/j.1600-0560.2002.290402.x, doi:10.1034/j.1600-0560.2002.290402.x. This article has 52 citations and is from a peer-reviewed journal.

  3. (ramessur2020eruptivepapulesin pages 1-2): Ravi Ramessur, George Meligonis, and Nigel P. Burrows. Eruptive papules in a 4‐year‐old girl. Pediatric Dermatology, Jan 2020. URL: https://doi.org/10.1111/pde.14023, doi:10.1111/pde.14023. This article has 0 citations and is from a peer-reviewed journal.

  4. (breier2002papularxanthomaa pages 2-4): Friedrich Breier, Bettina Zelger, Harald Reiter, Friedrich Gschnait, and Bernhard W. H. Zelger. Papular xanthoma: a clinicopathological study of 10 cases. Journal of Cutaneous Pathology, 29:200-206, Apr 2002. URL: https://doi.org/10.1034/j.1600-0560.2002.290402.x, doi:10.1034/j.1600-0560.2002.290402.x. This article has 52 citations and is from a peer-reviewed journal.

  5. (baykal2017theclinicalspectrum pages 1-2): Can Baykal, Algun Polat Ekinci, Kurtulus D. Yazganoglu, and Nesimi Buyukbabani. The clinical spectrum of xanthomatous lesions of the eyelids. International Journal of Dermatology, 56:981-992, May 2017. URL: https://doi.org/10.1111/ijd.13637, doi:10.1111/ijd.13637. This article has 38 citations and is from a peer-reviewed journal.

  6. (arbuckle2010casereport—papularxanthoma pages 1-3): Alan Arbuckle and Lori D. Prok. Case report—papular xanthoma in a 10‐year‐old female with abnormal lipid profile. Pediatric Dermatology, 27:86-88, Jan 2010. URL: https://doi.org/10.1111/j.1525-1470.2009.01054.x, doi:10.1111/j.1525-1470.2009.01054.x. This article has 9 citations and is from a peer-reviewed journal.

  7. (choudhary2015papularxanthomain pages 1-2): Nidhi Choudhary, Shruti Jadhav, Rahul Ahar, Arghyaprasun Ghosh, Joydeep Singha, and Archana Saha. Papular xanthoma in a child: report of a rare entity. Indian Journal of Paediatric Dermatology, 16:78-80, Apr 2015. URL: https://doi.org/10.4103/2319-7250.152139, doi:10.4103/2319-7250.152139. This article has 2 citations.

  8. (rebora2011periorbitallesions. pages 4-5): Alfredo Rebora. Periorbital lesions. Clinics in dermatology, 29 2:151-6, Mar 2011. URL: https://doi.org/10.1016/j.clindermatol.2010.09.006, doi:10.1016/j.clindermatol.2010.09.006. This article has 9 citations and is from a peer-reviewed journal.

  9. (francois2023multiplepapularxanthomas pages 2-3): Rony A. Francois, Grant J. Randall, Eric W. Rudnick, Stephanie J. Carstens, and Vladimir Vincek. Multiple papular xanthomas mimicking juvenile xanthogranulomas in an infant: a case report and review of the literature. Journal of Cutaneous Pathology, 50:1-7, May 2023. URL: https://doi.org/10.1111/cup.14244, doi:10.1111/cup.14244. This article has 0 citations and is from a peer-reviewed journal.

  10. (baykal2017theclinicalspectrum pages 4-6): Can Baykal, Algun Polat Ekinci, Kurtulus D. Yazganoglu, and Nesimi Buyukbabani. The clinical spectrum of xanthomatous lesions of the eyelids. International Journal of Dermatology, 56:981-992, May 2017. URL: https://doi.org/10.1111/ijd.13637, doi:10.1111/ijd.13637. This article has 38 citations and is from a peer-reviewed journal.

  11. (ramessur2020eruptivepapulesin pages 2-2): Ravi Ramessur, George Meligonis, and Nigel P. Burrows. Eruptive papules in a 4‐year‐old girl. Pediatric Dermatology, Jan 2020. URL: https://doi.org/10.1111/pde.14023, doi:10.1111/pde.14023. This article has 0 citations and is from a peer-reviewed journal.